Webinar - Anti-corruption by design : Understanding and tackling health system corruption on the road to Universal Health Coverage

Webinar: Tuesday 25 September 13:30 CEST / 11:30 GMT

Register here

Corruption is a matter of life and death in the health sector, impeding access, quality of care, financial protection and equity, disproportionately affecting the poor and vulnerable. The disruption that corruption induces in governance processes makes it a major hurdle in health system strengthening.

Its causes are multi-faceted; they are influenced by factors within and beyond the health sector, and a top-down anti-corruption enforcement approach may not always yield the expected results.

One of WHO's main axis of work in this field has been to encourage collaboration by convening various actors, sharing and consolidating technical know-how, building consensus on methods,  and synergizing approaches on anti-corruption, transparency, and accountability.

This session will introduce the work that WHO's Gender, Equity and Rights (GER) and Health Systems Governance and Financing (HGF) units have been undertaking together; and invite various partners to share the perspectives they have drawn from their own experience working on corruption.

We invite all interested stakeholders to join this session and engage in a discussion on the matter.

Agenda

This webinar will last for 90 minutes. It will be divided into the following five sections:

1. Introduction and roundtable: David Clarke will introduce the topic and describe how WHOs work has focused on a preventative approach to support the efforts of WHO Member States to strengthen anti-corruption, transparency and accountability mechanisms. [5 minutes]
2. Anti-corruption, transparency and accountability and the SDGs - introducing the new ACTA-WHO workstream: Taryn Vian will present the work undertaken by ACTA, clarifying concepts and frameworks. [15 minutes]
3. New perspectives on corruption: Mostafa Hunter and Sarah Steingrüber will present their own perspectives, including Corruption Risk Management for UHC. [15 minutes] 
4. Anti-Corruption Evidence research consortium: Dina Balabanova will introduce this project and its work at the country level before presenting the final findings in HSR2018 in Liverpool. [10 minutes] 
5. Open Discussion: We will invite all attendees to come forward and share their thoughts and reactions to the presentations. [45 minutes] 

The slides from the presentations will be in English and will be accessible online afterwards.

The webinar will be recorded and posted on the Collaborative's youtube channel.

Our speakers

David Clarke

David Clarke is a public health lawyer.  He is a senior health system advisor at WHO HQ in Geneva. David works in three main areas: using law and regulation to implement Universal Health Coverage (UHC), supporting countries to strategically engage the private sector in service of UHC and developing preventative approaches to mitigate the risk of health system corruption.

Dina Balabanova

Dina is an Associate Professor in Health Systems & Policy in the Department of Global Health and Development at LSHTM, with over 20 years of experience in health systems and policy research in low- and middle-income countries (LMICs). Her main expertise is in health systems governance, institution building and effective delivery models.

Mostafa Hunter

Mostafa Hunter is an international expert in governance, private sector engagement for public value and corruption risk management in the health sector. He took the lead on the development of several innovative approaches, conceptual frameworks and guides in those fields and has been an advisor to several UN agencies. He was awarded 2011 Rising Star of Corporate Governance from Yale School of Management and named a 2012 Global Proxy Watch Star.

Sarah Steingrüber

Sarah Steingrüber is the Programme Manager of Transparency International's global Pharmaceuticals & Healthcare Programme. She is responsible for the strategic development and implementation of a number of anti-corruption and health projects and supports the programme’s advocacy activities. Together with colleagues from the Centre for Global Development, the Global Fund and Harvard University, Sarah is co-authoring the forthcoming article, Designing Global Health Programs To More Effectively Mitigate Against Corruption Risk, as part of the journal Global Health Action’s upcoming issue on corruption in health, which is supported by WHO’s Anti-Corruption, Transparency and Accountability Group.

Taryn Vian

Taryn Vian is Clinical Professor and Associate Chair of Global Health at the Boston University School of Public Health. Her consulting, research, and teaching focus on corruption and health, leadership and management, and financial management.

Register here